Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00428
|
|||||
| Drug Name |
Prednisolone
|
|||||
| Synonyms |
Nanocort; Prednisolone (injectable liposome formulation, rheumatoid arthritis); Prednisolone (injectable liposome formulation, rheumatoid arthritis), Enceladus; Prednisolone (injectable liposome formulation, rheumatoid arthritis), Galapagos
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Multiple scierosis [ICD11: 8A40] | Approved | [1] | |||
| Adrenocortical insufficiency [ICD11: 5A74] | Approved | [1] | ||||
| Rheumatoid arthritis [ICD11: FA20] | Approved | [1] | ||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H28O5
|
|||||
| Canonical SMILES |
CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
|
|||||
| InChI |
InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1
|
|||||
| InChIKey |
OIGNJSKKLXVSLS-VWUMJDOOSA-N
|
|||||
| CAS Number |
CAS 50-24-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 360.4 | Topological Polar Surface Area | 94.8 | ||
| Heavy Atom Count | 26 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
1.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103189031
, 10321429
, 103913923
, 104169971
, 11466302
, 11467422
, 11486103
, 12012573
, 12146616
, 14876794
, 14876795
, 24870351
, 24898079
, 24898725
, 26697414
, 29224791
, 46504847
, 46519223
, 47500929
, 47647896
, 47945232
, 48244811
, 48414366
, 48416460
, 49698415
, 49857644
, 50085972
, 50124371
, 50643467
, 53790825
, 56311149
, 56312886
, 56313992
, 56463372
, 57288815
, 57650843
, 74674
, 75254
, 7847538
, 7980377
, 81093218
, 8153532
, 85300842
, 85788424
, 87574796
, 92125114
, 92309181
, 92710510
, 93576750
, 9573
|
|||||
| ChEBI ID |
CHEBI:8378
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Prednisolone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone. J Endocrinol. 2002 Oct;175(1):251-60. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.